Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2009 | 10-2008 | 07-2008 | 04-2008 | 01-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,901 | -968 | N/A | -4,870 | -3,859 |
| Depreciation Amortization | 32 | 16 | N/A | 54 | 36 |
| Accounts receivable | -169 | -132 | N/A | -208 | 60 |
| Other Working Capital | -76 | -324 | N/A | -350 | 373 |
| Other Operating Activity | 215 | 223 | 0 | 910 | 539 |
| Operating Cash Flow | $-1,899 | $-1,185 | $N/A | $-4,464 | $-2,851 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 823 | 823 |
| PPE Investments | -2 | -2 | N/A | -30 | -22 |
| Investing Cash Flow | $-2 | $-2 | $N/A | $793 | $801 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 363 | 100 | N/A | N/A | N/A |
| Other Financing Activity | -6 | -6 | 0 | 0 | 0 |
| Financing Cash Flow | $357 | $94 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,237 | 2,237 | N/A | 6,572 | 6,572 |
| End Cash Position | 694 | 1,146 | N/A | 2,901 | 4,522 |
| Net Cash Flow | $-1,543 | $-1,092 | $N/A | $-3,671 | $-2,050 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,899 | -1,185 | N/A | -4,464 | -2,851 |
| Capital Expenditure | -2 | -2 | N/A | -30 | -22 |
| Free Cash Flow | -1,900 | -1,186 | 0 | -4,494 | -2,873 |